02.11.2007 22:16:00
|
Advanced Medical Optics to Present at Two Investor Conferences in November 2007
Advanced Medical Optics, Inc. (AMO) (NYSE:EYE) today announced that
Chairman, President and CEO Jim Mazzo will present a corporate and
financial overview of the company at the Credit Suisse Phoenix Health
Care Conference on Wednesday, November 14 at 1:30pm EST.
AMO Chief Operating Officer Randy Meier is also scheduled to provide a
corporate and financial overview at the 19th
Annual Piper Jaffray Health Care Conference in New York City on
Wednesday, November 28 at 12:30pm EST.
To access an audio webcast of these presentations, please visit the
Investor section of AMO's Website at http://www.amo-inc.com.
About Advanced Medical Optics (AMO)
AMO is focused on providing the full range of advanced refractive
technologies and support to help eye care professionals deliver optimal
vision and lifestyle experiences to patients of all ages. Products in
the cataract/implant line include intraocular lenses (IOLs),
phacoemulsification systems, viscoelastics, and related products used in
ocular surgery. AMO owns or has the rights to such product brands as
ReZoom®, Tecnis®,
Clariflex®, Sensar®,
and Verisyse®
IOLs, Sovereign®,
Sovereign® Compact
and WhiteStar Signature™
phacoemulsification systems with WhiteStar®
technology, Healon®
viscoelastics, and the Baerveldt®
glaucoma shunt. Products in the laser vision correction line include
wavefront diagnostic devices, femtosecond lasers and associated patient
interface devices, and excimer laser vision correction systems and
treatment cards. AMO brands in the laser vision correction business
include Star S4 IR®,
WaveScan Wavefront®,
Advanced CustomVue™,
IntraLase®
and IntraLasik®.
Products in the contact lens care line include disinfecting solutions,
enzymatic cleaners and lens rewetting drops. Among the eye care product
brands the company possesses are COMPLETE®,
COMPLETE®
Blink-N-Clean®,
Consept®F, Consept®
1 Step, Oxysept® 1
Step, UltraCare®,
Ultrazyme®, Total
Care™ and blink™ branded products. AMO is based in Santa Ana, California, and
employs approximately 4,200 worldwide. The company has operations in 24
countries and markets products in approximately 60 countries. For more
information, visit the company's Website at www.amo-inc.com.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.
Nachrichten zu Abbott Laboratoriesmehr Nachrichten
Analysen zu Abbott Laboratoriesmehr Analysen
Aktien in diesem Artikel
Abbott Laboratories | 112,54 | 0,21% |
Indizes in diesem Artikel
S&P 600 SmallCap | 935,46 | -0,94% |